On 2025-05-01, NextCure, Inc. (NXTC) announced earnings per share of $-0.39 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.40.
The next expected annoucement date for quarterly earnings is 2025-08-07, with an average estimated earnings per share of $-0.38 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-01 | 2025-03-31 | $-0.40 | $-0.39 |
2025-03-06 | 2024-12-31 | $-0.34 | $-0.41 |
2024-11-07 | 2024-09-30 | $-0.35 | $-0.41 |
2024-08-01 | 2024-06-30 | $-0.36 | $-0.55 |
2024-05-02 | 2024-03-31 | $-0.45 | $-0.61 |
2024-03-21 | 2023-12-31 | $-0.54 | $-0.52 |
2023-11-02 | 2023-09-30 | $-0.64 | $-0.51 |
2023-08-03 | 2023-06-30 | $-0.60 | $-0.64 |
2023-05-04 | 2023-03-31 | $-0.64 | $-0.58 |
2023-03-02 | 2022-12-31 | $-0.65 | $-0.62 |
2022-11-03 | 2022-09-30 | $-0.60 | $-0.68 |
2022-08-04 | 2022-06-30 | $-0.73 | $-0.65 |
2022-05-05 | 2022-03-31 | $-0.68 | $-0.74 |
2022-03-03 | 2021-12-31 | $-0.67 | $-0.61 |
2021-11-04 | 2021-09-30 | $-0.67 | $-0.65 |
2021-08-05 | 2021-06-30 | $-0.60 | $-0.65 |
2021-05-06 | 2021-03-31 | $-0.57 | $-0.60 |
2021-03-04 | 2020-12-31 | $-0.58 | $-0.56 |
2020-11-05 | 2020-09-30 | $-0.56 | $-0.59 |
2020-08-06 | 2020-06-30 | $-0.45 | $-0.53 |
2020-05-07 | 2020-03-31 | $-0.58 | $0.33 |
2020-03-12 | 2019-12-31 | $-0.33 | $-0.34 |
2019-11-12 | 2019-09-30 | $-0.35 | $-0.37 |
2019-08-12 | 2019-06-30 | $-0.47 | $-0.61 |
2019-06-10 | 2019-03-31 | $-0.53 | $-4.46 |